Intervention
Placebo group
ClinicalTrials.gov intervention label
How to interpret these research links
Connected source recordsThis is the original ClinicalTrials.gov intervention label, found in 25 distinct published trials. Registry interventions may represent drugs, devices, procedures or other study activities. A matched term or study association does not establish product equivalence, efficacy or regulatory approval.
Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.
Advertisement
Clinical trials
25 shownNitrate, Exercise and Vascular Function in Midlife WomenNCT06527248 · 2025-03-31
RECRUITINGA Study of the Effectiveness and Safety of JS1-1-01 Tablet in Patients With Moderate to Severe DepressionNCT07485595 · 2026-04-30
NOT_YET_RECRUITINGValidation of a Novel Functional Food Designed to Meet the Nutritional Needs of People Living With Parkinson's DiseaseNCT06697626 · 2024-11-14
ACTIVE_NOT_RECRUITINGEffects of SugarCut® Unripe Guava Fruit Extract on Blood Glucose RegulationNCT06330948 · 2024-04-01
UNKNOWNA Study of the Effectiveness and Safety of JS1-1-01 in Patients With Moderate to Severe DepressionNCT06259526 · 2023-12-26
COMPLETEDEfficacy and Safety of Beta-glucan Supplement in Chronic Obstructive Pulmonary Disease PatientsNCT05878834 · 2023-05-25
COMPLETEDTo Evaluate the Beneficial Effect of Probiotics on DKD Patients and the Role of Gut Microbiota ModulationNCT05674981 · 2023-04-24
COMPLETEDThe Effect of Local Cold Application on HypertensionNCT04998526 · 2021-08-01
UNKNOWNMicroalgae Extract Phaeosol Combined to Exercise in Healthy Overweight Women : Efficacy on Body Weight ManagementNCT04761406 · 2021-04-26
COMPLETEDEfficacy and Safety of the Combination of Ten Elements for 6 Months in Patients With Diabetic Neuropathy : A Pilot StudyNCT05984771 · 2021-01-10
COMPLETEDBRain Energy Activation With Ketones to Prevent Alzheimer's DiseaseNCT04466735 · 2020-10-15
COMPLETEDCherries Role in Gut Microbiota-liver-brain FunctionNCT05586386 · 2020-02-06
COMPLETEDEffectiveness of Integrative and Complementary Practice in Health as a Strategy in Obesity TreatmentNCT04089384 · 2020-01-01
UNKNOWNMagnesium Sulfate Dose in Obese Patients.NCT04003688 · 2019-08-26
COMPLETEDPhotobiomodulation in Individuals With Chronic Obstructive Pulmonary DiseaseNCT04010084 · 2019-08-01
UNKNOWNEfficacy and Safety of AD-35 in Treatment of Subjects With Mild to Moderate Alzheimer's DiseaseNCT03625401 · 2018-10-04
UNKNOWNSynergic Effects of Physical Activity and Probiotic on Gut Immune System and Quality of Life of Breast Cancer Survivors.NCT03760653 · 2018-10-01
WITHDRAWNEffects of n-3 Intake on Lipid Profile, Biochemical and Inflammatory Markers in Subjects With ObesityNCT04901052 · 2018-01-10
COMPLETEDEffects of EPA in Men With Biochemical Recurrence or Progression of Prostate Cancer.NCT03753334 · 2017-07-10
ACTIVE_NOT_RECRUITINGDose-Finding Clinical Trial to Evaluate the Efficacy and Safety of LY03005 Extended-release Tablets in the Treatment of Major Depressive Disorder (MDD)NCT03785652 · 2015-10-09
COMPLETEDLong-term Retinal Changes After Topical Citicoline Administration in Patients With Mild Signs of Diabetic Retinopathy in Type 1 Diabetes Mellitus.NCT04009980 · 2015-09-23
COMPLETEDChanges in Body Adiposity by Dual Probiotic Strains Positively Correlated With Changes in Lp-PLA2 Activity in Overweight AdultsNCT02492698 · 2014-06-01
COMPLETEDHeart Failure Educational and Follow up PlatformNCT02110433 · 2013-12-01
COMPLETEDCan Whey Protein Improve Glycemic Control in Type 2 Diabetes?NCT01925248 · 2013-07-01
COMPLETEDAnti-Diabetic Effect of Gynostemma Pentaphyllum Tea as add-on Therapy With Sulfonylureas in Type 2 Diabetic PatientsNCT00808860 · 2008-02-01
COMPLETEDCommon conditions
Obesity4Depression2Dietary Supplement2Hypertension2Alzheimer Disease, Early Onset1Body Weight Changes1Breast Cancer Females1Chronic Heart Failure1Chronic Obstructive Pulmonary Disease1Chronic Obstructive Pulmonary Disease Patients1Constipation1Diabetes Mellitus1Diabetic Kidney Disease1Diabetic Neuropathies1Diabetic Retinopathy1Exercise1Healthy1Healthy Lifestyle1Hyperglycemia1Inflammation1Magnesium Sulfate1Major Depressive Disorder1MCI1Menopause1Overweight1
Mapped diseases appearing in these trials
Shared study participation does not establish that this intervention treats a disease.
Leading sponsors
Tasly Pharmaceutical Group Co., Ltd
2
Aristotle University Of Thessaloniki
1
Ataturk University
1
CHU de Quebec-Universite Laval
1
Chulalongkorn University
1
Fondazione G.B. Bietti, IRCCS
1
GenMont Biotech Incorporation
1
Hanoi Medical University
1
Hôpital NOVO
1
Luye Pharma Group Ltd.
1
Microphyt
1
National Yang Ming Chiao Tung University
1
Texas A&M University
1
Universidad Europea de Madrid
1
Université de Sherbrooke
1
Trial status mix
COMPLETED15
UNKNOWN5
ACTIVE_NOT_RECRUITING2
NOT_YET_RECRUITING1
RECRUITING1
WITHDRAWN1
Phase mix
NA17
PHASE25
PHASE13
PHASE32
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.